MARPS:NASDAQMarine Petroleum Trust Analysis
Data as of 2026-05-21 - not real-time
$4.96
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Marine Petroleum Trust is trading at $4.96, just above its near‑term support of $4.80 and below the 20‑day SMA of $4.99, while the 50‑day SMA sits higher at $5.11, indicating a modest short‑term weakness but overall neutral trend. Technical momentum shows a borderline bullish MACD (histogram +0.0075) and an RSI of 47.7, suggesting the stock is neither overbought nor oversold. Valuation metrics are mixed: the PE of 16 is well under the industry average of 21.7, pointing to potential undervaluation, yet the price‑to‑book of 9.8 and price‑to‑sales of 10.3 are elevated. The dividend yield of 6.36% is attractive, but the payout ratio exceeds 100%, raising sustainability concerns.
Fundamentally, the trust reports a 31% revenue decline and a gross margin of 100% typical of royalty structures, with strong operating margins (57.6%) and ROE (65.6%). However, operating and free cash flow are reported as zero, and liquidity is thin – average daily volume is under 1,000 shares versus a 10‑day average of 6,390, resulting in high liquidity risk. Volatility is high at 36.5% over the past 30 days, while a negative beta (‑0.73) suggests inverse market correlation, offering some defensive characteristics. The combination of attractive income, modest valuation, but significant earnings volatility and dividend sustainability issues makes the stock a nuanced play.
Fundamentally, the trust reports a 31% revenue decline and a gross margin of 100% typical of royalty structures, with strong operating margins (57.6%) and ROE (65.6%). However, operating and free cash flow are reported as zero, and liquidity is thin – average daily volume is under 1,000 shares versus a 10‑day average of 6,390, resulting in high liquidity risk. Volatility is high at 36.5% over the past 30 days, while a negative beta (‑0.73) suggests inverse market correlation, offering some defensive characteristics. The combination of attractive income, modest valuation, but significant earnings volatility and dividend sustainability issues makes the stock a nuanced play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram indicating slight upward momentum
- Price comfortably above immediate support level
- High liquidity risk due to very low trading volume
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- PE well below industry average suggesting relative cheapness
- Attractive dividend yield despite payout concerns
- Negative beta offering potential hedge against broader market moves
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained revenue decline of 31% year‑over‑year
- Dividend payout ratio above 100% questioning long‑term sustainability
- Elevated volatility and high drawdown risk
Key Metrics & Analysis
Financial Health
Revenue Growth-31.10%
Profit Margin65.24%
P/E Ratio16.0
ROE65.62%
ROA41.01%
P/B Ratio9.8
Industry P/E21.7
Technical Analysis
TrendNeutral
RSI47.7
Support$4.80
Resistance$5.28
MA 20$4.99
MA 50$5.11
MA 200$4.71
MACDBullish
VolumeDecreasing
Fear & Greed Index89.91
Valuation
GradeUndervalued
TypeValue
Dividend Yield6.36%
Risk Assessment
Beta-0.73
Volatility36.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.